Prof Anne-Marie Imafidon MBE
Future of Work & Digital Transformation Speaker for Healthcare & Pharma
Prof Anne-Marie Imafidon MBE works with healthcare organisations and pharmaceutical leaders navigating a fundamental shift: how to modernise clinical practice, drug development, and workforce capability in response to rapid technological change.
Her sessions focus on helping leaders understand not just what emerging technologies — including AI — can do, but how they can be applied in highly regulated, patient-centred environments where safety, ethics, and long-term decision-making all matter.
Where Anne-Marie Is Most Relevant
Anne-Marie’s sessions are particularly valuable for organisations managing transformation across clinical delivery, research, operations, and workforce capability.
She is most relevant for:
- Healthcare providers and NHS organisations integrating AI into clinical workflows and patient care
- Pharmaceutical and life sciences leaders accelerating drug discovery and digital innovation
- Organisations balancing technological advancement with regulation, governance, and patient safety
- Teams modernising data infrastructure, research capability, and care models
- Leaders addressing digital and data skills gaps across clinical, scientific, and operational teams
- Organisations focused on improving patient outcomes whilst maintaining trust and human-centred care
Trends & Challenges in Healthcare & Pharma
Healthcare and pharmaceutical organisations face a convergence of pressures unlike any other sector: the race to deploy AI at scale, mounting regulatory scrutiny, a clinical workforce stretched thin, and patients who expect the benefits of technology without losing the human care at the heart of medicine.
Prof Anne-Marie Imafidon understands these tensions and focuses on where technology can be applied practically to improve patient outcomes, operational performance, and workforce capability in highly regulated environments.
💊 Digital Therapeutics
Software is becoming medicine. Anne-Marie shows how AI-powered therapeutics are moving from trials into real-world care — and what this means for regulation, workforce capability, and product strategy.
🧬 Biosynthetics & the Biotech Frontier
From synthetic biology to AI-designed proteins, the line between data science and drug discovery is dissolving.
Anne-Marie helps leaders understand how computational tools accelerate biosynthetic research — and how organisations build the talent and infrastructure to keep pace.
🔭 360 View of a Person
Care increasingly depends on a continuous, data-driven understanding of the individual.
Anne-Marie examines how AI and connected health systems enable more personalised and predictive care — and what responsible implementation looks like at scale.
🚚 Autonomous Supply Chain
Supply chains must remain resilient without compromising patient access.
Anne-Marie highlights how intelligent systems improve reliability, reduce waste, and respond to disruption across pharmaceutical logistics.
🔐 Cyber & Data Security
Healthcare organisations are among the most targeted in the world. As digitisation accelerates, so does exposure.
Anne-Marie breaks down the cyber landscape and equips leaders to make better decisions about risk, resilience, and governance.
🌍 Inclusive Innovation
Diverse teams produce better science and safer systems.
Anne-Marie connects representation directly to patient safety, commercial outcomes, and equitable healthcare delivery.
Recent Healthcare & Pharma Keynotes
Specifically designed for healthcare providers, pharmaceutical companies, and life sciences organisations, these presentations address the operational, regulatory, and workforce challenges facing leaders today.
The Tech Landscape and Why It Needs Diversity
Tech is a booming industry with growing importance in any given economy, yet suffers from a large skills shortage and low representation of women. Anne-Marie dissects the HERstory of the tech industry and what it means for future innovators.
Key Takeaways:
- A clearer understanding of how diverse clinical AI teams improve patient safety and outcomes
- New perspectives onattracting and retaining digitally literate, diverse talent in a competitive market
- Practical ways to strengthen fairness in data-driven healthcare decision-making
- Greater awareness of how bias impacts diagnostics, drug discovery, and patient risk models
Best for:
Leaders focused on talent, innovation, and equitable patient outcomes.
AI & The Future of Work
A comical, yet real, look at how AI is already reshaping healthcare and pharmaceutical work.
Key Takeaways:
- A grounded view of where AI is already changing clinical workflows and operations
- Practical ways to apply AI across drug discovery, clinical trials, and patient communication
- New perspectives on how to rebalance clinical and scientific time towards higher-value work
- A clearer understanding of how roles will evolve across clinical, research, and leadership teams
- Ideas for new care models and product opportunities enabled by data at scale
Best for:
Organisations focused on operational efficiency, innovation, and workforce transformation
Transforming Fear into Fuel: the Continual Evolution of Tech
A session focused on how organisations respond to ongoing technological change — turning uncertainty into action.
Anne-Marie draws on cross-sector insights to help teams move from awareness to practical adoption.
Key Takeaways:
- A more confident approach to adopting AI within clinical and scientific environments
- Practical ways to extend existing expertise with new tools, rather than replace it
- Clearer approaches to supporting teams through change in regulated, high-stakes settings
- A stronger understanding of how to move from experimentation to consistent application
Best for:
Organisations focused on adoption, capability, and cultural change
Taking CTRL / She’s in CTRL
Anne-Marie shares practical ways to operate effectively in a digital healthcare and life sciences environment.
Key Takeaways:
- Practical ways to apply digital tools across clinical, research, and operational workflows
- New approaches to decision-making where patient safety, ethics, and accountability are critical
- Greater confidence in navigating data-driven systems in regulated environments
- A clearer sense of how clinicians, researchers, and leaders can build digital capability in day-to-day work
Best for:
Organisations focused on practical capability and day-to-day performance
Why Healthcare & Pharma Needs Diversity
The case for diversity in healthcare and life sciences has never been more urgent.
Anne-Marie explores how diversity in clinical AI, drug development, and leadership directly impacts patient outcomes, risk, and innovation.
Key Takeaways:
- A clearer understanding of how bias in clinical AI and research affects patient outcomes
- Greater awareness of where homogeneity introduces risk into diagnostics, treatment, and data models
- Practical ways to close the representation gap: research, leadership, and medtech development
- New perspectives on how inclusion improves both patient relevance and scientific quality
- A stronger link between team composition, innovation, and long-term performance
Best for:
Organisations focused on improving patient outcomes, reducing risk, and strengthening innovation
Deep Technology Expertise
Prof Anne-Marie Imafidon MBE brings a rare perspective to healthcare and life sciences — combining genuine technical mastery with a front-line understanding of how AI and automation are transforming professional work in complex, regulated environments.
As Founder of Stemettes and current Chair of the Institute for the Future of Work, Anne-Marie works at the intersection of technology, workforce change, and inclusive innovation — three forces reshaping healthcare faster than most organisations are ready for.
A recognised prodigy who passed A-level computing at age 11 and earned a Master’s degree in Mathematics and Computer Science from Oxford at 20, she brings the technical depth to interrogate clinical AI credibly, and the communication skills to make complex ideas accessible and actionable for non-technical audiences.
Voted the most influential woman in tech in the UK in 2020 and awarded an MBE in 2017 for services to STEM, Anne-Marie is a trusted voice on technology, diversity, and the future of work across regulated, high-stakes sectors.
Deep Impact: Tech Industry and beyond
70,000+
Young people inspired through Stemettes
200+
Global keynote presentations
MBE
Awarded 2017 for services to STEM
Trusted by Leading Organisations
From global pharmaceutical firms and medical technology companies to NHS organisations and public health bodies, Prof Anne-Marie Imafidon MBE has helped leaders across sectors navigate digital transformation and build more inclusive, future-ready organisations.
Goldman Sachs · Deutsche Bank · Google · Facebook · ASOS · Mercedes-Benz · Mastercard · Fujitsu
What Leaders Are Saying
Audiences consistently praise Anne-Marie’s ability to make complex technology accessible whilst challenging organisations to think differently about talent, innovation, and the future of professional work.
“Anne-Marie was wonderful as ever. She is so engaging and is the perfect host for this award ceremony.”
NHS
‘Anne-Marie was really engaging so we were delighted to have her as a speaker!’
Roche Products
“We received so many messages throughout about how fantastic Anne-Marie was and everyone in the room – and watching remotely – was absolutely mesmerized.”
GCI Health
Ready to transform your approach to technology and talent in healthcare & pharma?
Book Prof Anne-Marie Imafidon MBE to help your organisation apply AI responsibly, strengthen capability, and build more effective, future-ready teams.
Contact michael@speakingoffice.com at Speaking Office to discuss your event.